Management of Eclampsia
A pregnant patient with eclampsia requires immediate magnesium sulfate administration for seizure control and prevention, urgent blood pressure management if severely hypertensive (≥160/110 mmHg), and delivery once the patient is stabilized, as delivery is the only definitive treatment. 1, 2
Immediate Seizure Management
The cornerstone of eclampsia treatment is magnesium sulfate, which is the drug of choice for both stopping active convulsions and preventing recurrent seizures 2, 1. The standard regimen consists of:
- Loading dose: 4 g IV or 10 g IM 1
- Maintenance: 5 g IM every 4 hours OR 1 g/hour IV infusion 1
- Duration: Continue until delivery and for at least 24 hours postpartum 1
Magnesium sulfate is well-established for severe preeclampsia and eclampsia, though its exact mechanism remains unclear 2. Monitor for toxicity (absent reflexes, bradypnea, respiratory arrest); the antidote is 10 ml of 10% calcium gluconate or calcium chloride given by slow IV injection 3.
Blood Pressure Control
Severe hypertension (>160/110 mmHg) requires urgent treatment in a monitored setting 1. First-line antihypertensive agents include:
- Oral nifedipine (5-10 mg; repeat after 30 minutes if inadequate response) 4
- IV labetalol (10 mg initially; if inadequate after 10 minutes, give 20 mg) 1, 4
- IV hydralazine (5 mg slowly; repeat every 5 minutes until BP goal achieved) 1, 4
Critical caveat: Avoid sublingual or rapid IV nifedipine, as excessive BP reduction can cause myocardial infarction or fetal distress 2. Additionally, combining calcium channel blockers with IV magnesium may cause myocardial depression 2.
Target diastolic BP of 85 mmHg (systolic 110-140 mmHg) to prevent severe hypertension while maintaining uteroplacental perfusion 1.
Supportive Care and Monitoring
Fluid management is crucial: Restrict fluids to 80 ml/hour to prevent pulmonary edema, as uteroplacental perfusion is already compromised 4. Monitor input/output hourly 4.
Maternal monitoring should include:
- BP every 15-30 minutes during acute phase 4
- Clinical assessment including reflexes and clonus 1
- Continuous assessment for signs of end-organ dysfunction 2
Fetal surveillance is essential, as close monitoring helps determine timing of delivery 2.
Delivery Planning
Delivery is the only definitive treatment for eclampsia 2. Once the patient is stabilized after seizure control and BP management, expedite delivery 4.
Mode of delivery considerations:
- Eclampsia itself does not mandate cesarean section 4
- Individualize based on gestational age, maternal/fetal status, labor progress, and how rapidly delivery must occur 1, 4
- Vaginal delivery is acceptable if conditions permit quick completion with stable maternal-fetal status 5
- Cesarean section is often necessary for rapid stabilization 6, 5
Anesthesia considerations:
- Regional anesthesia (epidural/spinal) can be used only in conscious patients free from coagulopathy and HELLP syndrome 5
- General anesthesia may be necessary for sudden interventions or when lab results are unavailable 5
- Maintain left lateral positioning during cesarean section 5
Additional Interventions
If gestational age <34 weeks: Administer corticosteroids for 48 hours to accelerate fetal lung maturation 2.
Avoid diuretics: They are contraindicated as uteroplacental perfusion is already reduced in preeclampsia/eclampsia 2.
Timing and Prognosis
Eclamptic seizures can occur antepartum (38-53%), intrapartum (18-36%), or postpartum (11-44%), with increasing recognition of cases beyond 48 hours postpartum 7. Perinatal mortality is significantly reduced when treatment is initiated within 6 hours of the first convulsion 6.
The development of eclampsia increases risk of adverse outcomes for both mother and fetus, particularly in developing nations 7. However, with appropriate management including early magnesium sulfate administration and decisive delivery planning, maternal survival rates exceed 50% and fetal viability can be optimized 3, 6.
Post-Delivery Counseling
Women with eclampsia history face increased risk in subsequent pregnancies: 1-2% recurrence of eclampsia and 22-35% risk of preeclampsia 7. They also have lifelong increased risk of chronic hypertension and cardiovascular disease, requiring long-term medical follow-up 8.